Cargando…
Quality assessment of nine paracetamol 500 mg tablet brands marketed in Saudi Arabia
OBJECTIVE: To evaluate in-vitro quality of paracetamol 500 mg tablet brands marketed in Saudi Arabia. RESULTS: Two reference (R1 and R2) and seven generic (G1-G7) brands were commercially available. Four brands were single-drug, containing paracetamol only (R1, G1-G3) and five contained additional a...
Autores principales: | AlSwayeh, Reem, Alvi, Syed N., Hammami, Muhammad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247153/ https://www.ncbi.nlm.nih.gov/pubmed/34193274 http://dx.doi.org/10.1186/s13104-021-05672-y |
Ejemplares similares
-
Eight enteric-coated 50 mg diclofenac sodium tablet formulations marketed in Saudi Arabia: in vitro quality evaluation
por: Hammami, Muhammad M., et al.
Publicado: (2020) -
Pharmaceutical quality of seven brands of diclofenac tablet on the Saudi market
por: Hammami, Muhammad M., et al.
Publicado: (2020) -
Quality assessment of different brands of atorvastatin tablets available in Riyadh, Saudi Arabia
por: AlMuhsin, Ali, et al.
Publicado: (2022) -
Evaluating the bioequivalence of levetiracetam brand and generic oral tablets available in the Saudi market in vivo
por: ALRabeeah, Danah, et al.
Publicado: (2023) -
Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs
por: Hammami, Muhammad M., et al.
Publicado: (2017)